Virtu Financial’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-38,479
| Closed | -$2.17M | – | 1625 |
|
|
2026
Q1 | $2.17M | Buy |
+38,479
| New | +$2.24M | 0.09% | 143 |
|
|
2024
Q4 | – | Sell |
-11,504
| Closed | -$809K | – | 1567 |
|
|
2024
Q3 | $809K | Buy |
+11,504
| New | +$962K | 0.04% | 309 |
|
|
2022
Q4 | – | Sell |
-10,575
| Closed | -$896K | – | 1635 |
|
|
2022
Q3 | $896K | Buy |
+10,575
| New | +$942K | 0.08% | 220 |
|
|
2022
Q2 | – | Sell |
-12,122
| Closed | -$935K | – | 1602 |
|
|
2022
Q1 | $935K | Buy |
+12,122
| New | +$1.01M | 0.07% | 230 |
|
|
2021
Q4 | – | Sell |
-3,700
| Closed | -$286K | – | 1724 |
|
|
2021
Q3 | $286K | Buy |
+3,700
| New | +$292K | 0.03% | 738 |
|
|
2020
Q4 | – | Sell |
-18,026
| Closed | -$1.37M | – | 1449 |
|
|
2020
Q3 | $1.37M | Buy |
+18,026
| New | +$1.82M | 0.24% | 85 |
|
|
2019
Q4 | – | Sell |
-7,759
| Closed | -$523K | – | 1451 |
|
|
2019
Q3 | $523K | Buy |
+7,759
| New | +$598K | 0.04% | 495 |
|
|
2019
Q2 | – | Sell |
-14,015
| Closed | -$1.25M | – | 1472 |
|
|
2019
Q1 | $1.25M | Buy |
14,015
+10,029
| +252% | +$930K | 0.07% | 251 |
|
|
2018
Q4 | $339K | Sell |
3,986
-3,308
| -45% | -$315K | 0.02% | 660 |
|
|
2018
Q3 | $707K | Buy |
+7,294
| New | +$728K | 0.04% | 450 |
|
|
2018
Q1 | – | Sell |
-3,019
| Closed | -$269K | – | 1973 |
|
|
2017
Q4 | $269K | Sell |
3,019
-1,146
| -28% | -$99.6K | 0.01% | 1360 |
|
|
2017
Q3 | $388K | Buy |
+4,165
| New | +$368K | 0.02% | 1136 |
|
|
2016
Q4 | – | Sell |
-3,171
| Closed | -$293K | – | 448 |
|
|
2016
Q3 | $293K | Buy |
+3,171
| New | +$299K | 0.05% | 276 |
|
|
2016
Q1 | – | Sell |
-2,994
| Closed | -$314K | – | 402 |
|
|
2015
Q4 | $314K | Buy |
+2,994
| New | +$313K | 0.04% | 287 |
|
|
2015
Q3 | – | Sell |
-5,220
| Closed | -$714K | – | 320 |
|
|
2015
Q2 | $714K | Buy |
+5,220
| New | +$647K | 0.06% | 172 |
|
|
2014
Q4 | – | Sell |
-3,668
| Closed | -$265K | – | 308 |
|
|
2014
Q3 | $265K | Buy |
+3,668
| New | +$241K | 0.03% | 239 |
|
Other funds holding BMRN
VPC
Virtu Financial's BMRN Position: Q2 2026 in Review
Virtu Financial sold out of BioMarin Pharmaceuticals (BMRN) in Q2 2026, closing a stake of 38,479 shares — an estimated $2.17M sold.
Virtu Financial first reported a position in BMRN in Q3 2014 and held it in 16 quarters. The position peaked at $2.17M in Q1 2026. 565 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.
- Virtu Financial reported no remaining BioMarin Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Virtu Financial sold 38,479 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $2.17M.
- Virtu Financial first reported a position in BioMarin Pharmaceuticals in Q3 2014 and held it in 16 quarters.
- Virtu Financial's BioMarin Pharmaceuticals position peaked at $2.17M in Q1 2026.
- 565 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.
Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.